Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00088348 · ClinicalTrials.gov registry record
Screening for Research Subjects With Anterior Segment Diseases
A clinical trial, sponsored by National Eye Institute (NEI).
- Completed
- Registry status
- 600
- Enrollment target
NCT00088348: Completed study, sponsored by National Eye Institute (NEI).
NCT00088348 is a clinical trial that has completed, run by National Eye Institute (NEI). The registered enrollment target is 600 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00088348 has completed, sponsored by National Eye Institute (NEI).
- COMPLETED
- Registry status
- 600 participants
- Enrollment target
Study Summary
This study will identify patients with anterior segment disease who may be eligible to participate in current or future NEI studies on this disease. Anterior segment disease includes all disorders that affect the eye surface, anterior chamber, iris and ciliary body and lens of the eye. The eye surface is composed of the cornea, conjunctiva, eyelids, lacrimal and meibomian glands, and the interconnecting nerves. Patients of any age with anterior segment disease may be eligible for this screening study. Participants will be evaluated with some or all of the following tests and procedures, depending on the nature of their eye problem: * Medical history and brief physical examination. * Eye examination, including measurement of visual acuity (eye chart) and eye pressure, examination of the pupils, eye movements, structures in the front of the eye (cornea, conjunctive, etc.), the lens, and the structures in the back of the eye (retinal, optic nerve, etc.). * Photographs of the eye to help assess the status of the cornea and conjunctive and to evaluate any changes that may occur in the future. * Assessment of tear and surface status. The amount of tears the eyes can produce is measured by placing a small piece of sterile paper in the corner of the eye every 5 minutes. Special orange and green dyes are placed in the eyes to determine the health status of the surface of the eye. * Corneal or conjunctival biopsy. A small tissue sample from the surface of the eye may be removed for laboratory examination to help diagnose a condition that is unclear. For this procedure, the eye is numbed with anesthetic eye drops. The required tissue is collected, an antibiotic ointment is placed in the eye to prevent infection, and a patch may be placed over the eye for 12 to 24 hours. * Blood draw for tests to study the cause of the patient's eye disease. * Other diagnostic tests as needed. * DNA testing to look for a genetic pattern associated with the patient's eye disease. Patients who
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2004-07-13 |
| Est. Completion | 2008-08-20 |
What the finished NCT00088348 record still lists
NCT00088348 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00088348 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00088348 about?
NCT00088348 is a clinical study titled "Screening for Research Subjects With Anterior Segment Diseases". This study will identify patients with anterior segment disease who may be eligible to participate in current or future NEI studies on this disease. Anterior segment disease includes all disorders that affect the eye surface, anterior chamber, iris and ciliary body and lens of the eye. The eye surfa...
What is the current status of trial NCT00088348?
This trial is currently completed. The enrollment target is 600 participants. The study started on 2004-07-13. Estimated completion is 2008-08-20.
Who is sponsoring clinical trial NCT00088348?
This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI